Q4 2023 Holdings
Filed 2024-02-14 | 34 holdings | $1.1B | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2024-02-15) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $170.8M | 5,511,721 | 15.4% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $147.2M | 10,373,715 | 13.3% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $144.7M | 1,500,749 | 13.0% |
| Biogen Inc(BIIB) | COM | 09062X103 | $98.4M | 380,417 | 8.9% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $87.0M | 395,784 | 7.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $75.4M | 2,409,556 | 6.8% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $60.3M | 1,660,057 | 5.4% |
| Revance Therapeutics Inc(RVNCEUR) | COM | 761330109 | $46.0M | 5,237,284 | 4.1% |
| Staar Surgical Co(STAA) | COM PAR $0.01 | 852312305 | $43.0M | 1,376,950 | 3.9% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $29.6M | 154,437 | 2.7% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $23.9M | 2,739,379 | 2.2% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $21.5M | 991,525 | 1.9% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $19.4M | 200,905 | 1.7% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $17.1M | 2,106,792 | 1.5% |
| Alkermes PLC(ALKS) | SHS | G01767105 | $16.7M | 603,400 | 1.5% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $16.1M | 750,371 | 1.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $15.3M | 55,705 | 1.4% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $14.7M | 686,882 | 1.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.2M | 472,600 | 0.9% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $9.3M | 111,717 | 0.8% |
| Novocure LTD(NVCR) | ORD SHS | G6674U108 | $8.4M | 561,908 | 0.8% |
| Verve Therapeutics Inc | COM | 92539P101 | $8.0M | 575,817 | 0.7% |
| Gossamer BIO Inc(GOSS)A | COM | 38341P102 | $6.5M | 5,958,888 | 0.6% |
| Bluebird BIO Inc | COM | 09609G100 | $4.6M | 3,333,333 | 0.4% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $4.4M | 5,102,193 | 0.4% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $3.0M | 732,400 | 0.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.9M | 64,700 | 0.2% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $1.2M | 278,985 | 0.1% |
| Vyne Therapeutics Inc Pipe(VYNE) | COM | 92941V308 | $1.0M | 445,434 | 0.1% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $995.4K | 110,719 | 0.1% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $937.9K | 529,861 | 0.1% |
| Sight Sciences Inc(SGHT) | COM | 82657M105 | $896.8K | 173,790 | 0.1% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $791.4K | 225,465 | 0.1% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $367.5K | 24,500 | 0.0% |